Growth and Expansion Althea has demonstrated significant capacity for expansion, exemplified by opening a new 57,000-square-foot pharmaceutical manufacturing facility in San Diego, highlighting their need for scalable infrastructure and advanced manufacturing technologies.

Market Position As a leading contract development and manufacturing organization focused on biopharmaceuticals, Althea offers comprehensive services from process development to commercial manufacturing, presenting opportunities to collaborate on early-stage and high-potency drug projects.

Technological Capabilities Utilizing a robust tech stack including modern web technologies, Althea emphasizes its operational sophistication and commitment to quality, which could align with clients seeking high-tech, reliable manufacturing partners.

Financial Landscape With revenues estimated between 100 million to 250 million dollars, Althea exhibits a healthy financial profile, making it a dependable partner with potential investment or expanded service needs in drug formulation and aseptic fill finish.

Market Opportunities Given the similarities with other multi-billion dollar companies catering to biotech and pharma sectors, Althea presents a strong opportunity for sales efforts targeting biopharmaceutical companies requiring flexible, high-quality manufacturing solutions in competitive markets.